Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
Radiother Oncol
    August 2024
  1. ALKNER S, Wieslander E, Lundstedt D, Berg M, et al
    Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.
    Radiother Oncol. 2024;197:110372.
    >> Share

  2. FRANCESCHINI D, Teriaca MA, Mancosu P, Bertolini A, et al
    Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases.
    Radiother Oncol. 2024;197:110335.
    >> Share

    July 2024
  3. BOERSMA LJ, Bijker N, Stam MR
    Reporting breast cancer radiation therapy details in studies and daily practice: Nice-to-have or a must-have?
    Radiother Oncol. 2024 Jul 17:110429. doi: 10.1016/j.radonc.2024.110429.
    >> Share

  4. OVERGAARD J, Ccm Hulshof M, Dahl O, Arcangeli G, et al
    ESHO 1-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic Oncology.
    Radiother Oncol. 2024;196:110313.
    >> Share

    June 2024
  5. SONG YC, Chen SY, Zhao XR, Jing H, et al
    Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.
    Radiother Oncol. 2024 Jun 17:110390. doi: 10.1016/j.radonc.2024.110390.
    >> Share

  6. CACHO-DIAZ B, Valdes-Ferrer SI, Chavez-MacGregor M, Salmeron-Moreno K, et al
    Brain metastasis risk prediction model in females with hormone receptor-positive breast cancer.
    Radiother Oncol. 2024 Jun 9:110379. doi: 10.1016/j.radonc.2024.110379.
    >> Share

  7. CHRIST SM, Alongi F, Ricardi U, Scorsetti M, et al
    Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E(2)-RADIatE OligoCare study.
    Radiother Oncol. 2024;195:110235.
    >> Share

    May 2024
  8. HOGSBJERG KW, Offersen BV
    Author's response to Letter-to-the-Editor from Chang JS. concerning: "Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial".
    Radiother Oncol. 2024;197:110351.
    >> Share

  9. CHEN F, Zhou P, Ren G, Lee EKW, et al
    Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancer.
    Radiother Oncol. 2024;197:110333.
    >> Share

  10. HANNOUN-LEVI JM, Gimeno Morales M, Gal J, Anchuelo J, et al
    Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort.
    Radiother Oncol. 2024;194:110217.
    >> Share

  11. CICCHETTI A, Mangili P, Fodor A, Gabellini MGU, et al
    Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy.
    Radiother Oncol. 2024;194:110183.
    >> Share

    April 2024
  12. REFSGAARD L, Skarso Buhl E, Yates E, Maae E, et al
    Evaluating Danish Breast Cancer Group locoregional radiotherapy guideline adherence in clinical treatment data 2008-2016: The DBCG RT Nation study.
    Radiother Oncol. 2024 Apr 25:110289. doi: 10.1016/j.radonc.2024.110289.
    >> Share

    March 2024
  13. FRANCESCHINI D, Franzese C, Comito T, Ilieva MB, et al
    Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
    Radiother Oncol. 2024;195:110240.
    >> Share

  14. HUIJSKENS S, Granton P, Fremeijer K, van Wanrooij C, et al
    Clinical practicality and patient performance for surface-guided automated VMAT gating for DIBH breast cancer radiotherapy.
    Radiother Oncol. 2024 Mar 14:110229. doi: 10.1016/j.radonc.2024.110229.
    >> Share

  15. KUBECZKO M, Jarzab M, Gabrys D, Krzywon A, et al
    Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839].
    Radiother Oncol. 2024;194:110188.
    >> Share

  16. HOGSBJERG KW, Maae E, Nielsen MH, Stenbygaard L, et al
    Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial.
    Radiother Oncol. 2024 Mar 3:110195. doi: 10.1016/j.radonc.2024.110195.
    >> Share

  17. GIMENO-MORALES M, Martinez-Monge R, Martinez-Lage A, Jablonska PA, et al
    Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients.
    Radiother Oncol. 2024;194:110193.
    >> Share

    February 2024
  18. RAUFF SONDERGAARD S, Bechmann T, Maae E, Molby Nielsen AW, et al
    Shared decision making with breast cancer patients - does it work? Results of the cluster-randomized, multicenter DBCG RT SDM trial.
    Radiother Oncol. 2024 Feb 3:110115. doi: 10.1016/j.radonc.2024.110115.
    >> Share

  19. WINTRAECKEN VM, Boersma LJ, van Roozendaal LM, de Vries J, et al
    Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial.
    Radiother Oncol. 2024;191:110069.
    >> Share

  20. OLLONI A, Lorenzen EL, Jeppesen SS, Diederichsen A, et al
    An open source auto-segmentation algorithm for delineating heart and substructures - Development and validation within a multicenter lung cancer cohort.
    Radiother Oncol. 2024;191:110065.
    >> Share

    January 2024
  21. WHELAN TJ, Fyles A, Parpia S, Nielsen T, et al
    LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy.
    Radiother Oncol. 2024;190:110074.
    >> Share

  22. MEATTINI I, Marta GN, Carroll S, Rivera S, et al
    Omission of radiation therapy after breast-conserving surgery for biologically favourable tumours in younger patients: The wrong answer to the right question.
    Radiother Oncol. 2024;190:110045.
    >> Share

    December 2023
  23. SUK CHANG J, Lee J, Vicini FA, Sung Kim J, et al
    Large Institutional Experience of Early Outcomes and Dosimetric Findings with Postoperative Stereotactic Partial Breast Irradiation in Breast Cancer.
    Radiother Oncol. 2023 Dec 22:110066. doi: 10.1016/j.radonc.2023.110066.
    >> Share

  24. KAIDAR-PERSON O, Meattini I, Boersma LJ, Becherini C, et al
    Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European SocieTy for Radiotherapy and Oncology (ESTRO).
    Radiother Oncol. 2023 Dec 18:110060. doi: 10.1016/j.radonc.2023.110060.
    >> Share

    November 2023
  25. BUSSCHAERT SL, Kimpe E, Barbe K, De Ridder M, et al
    Introduction of ultra-hypofractionation in breast cancer: implications for costs and resource use.
    Radiother Oncol. 2023 Nov 11:110010. doi: 10.1016/j.radonc.2023.110010.
    >> Share

  26. YEONG SONG J, Guk Han M, Kim Y, Ji Kim M, et al
    Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model.
    Radiother Oncol. 2023 Nov 2:109981. doi: 10.1016/j.radonc.2023.109981.
    >> Share

    October 2023
  27. CHEN M, Xiao L, Jia H, Wang S, et al
    Stereotactic ablative radiotherapy and FAPalpha-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer.
    Radiother Oncol. 2023 Oct 6:109946. doi: 10.1016/j.radonc.2023.109946.
    >> Share

    September 2023
  28. SALVESTRINI V, Kim K, Caini S, Alkner S, et al
    Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis.
    Radiother Oncol. 2023;186:109805.
    >> Share

    August 2023
  29. AZNAR MC, Carrasco de Fez P, Corradini S, Mast M, et al
    ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy.
    Radiother Oncol. 2023;185:109734.
    >> Share

  30. FAYDA M
    Having ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patients.
    Radiother Oncol. 2023;185:109722.
    >> Share

  31. KUBECZKO M, Jarzab M, Gabrys D, Krzywon A, et al
    Safety and Feasibility of CDK4/6 Inhibitors Treatment Combined with Radiotherapy in Patients with HR-positive/HER2-negative Breast Cancer A Systematic Review and Meta-analysis.
    Radiother Oncol. 2023 Aug 1:109839. doi: 10.1016/j.radonc.2023.109839.
    >> Share

    July 2023
  32. LE BRAS A, Belkacemi Y, Bourgier C, Gabelle-Flandin I, et al
    Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized
    Radiother Oncol. 2023 Jul 20:109818. doi: 10.1016/j.radonc.2023.109818.
    >> Share

  33. JANDU HK, Veal CD, Fachal L, Luccarini C, et al
    Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
    Radiother Oncol. 2023 Jul 10:109806. doi: 10.1016/j.radonc.2023.109806.
    >> Share

    June 2023
  34. LOUISE HOLM MILO M, Vrou Offersen B
    Response to "letter to the Editor of Radiotherapy and Oncology regarding the paper titled Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation the
    Radiother Oncol. 2023 Jun 14:109733. doi: 10.1016/j.radonc.2023.109733.
    >> Share

    May 2023
  35. SAIFI O, Zeidan YH
    One Size Does Not Fit All: PMRT in ypN0 HER-2 Positive Breast Cancer.
    Radiother Oncol. 2023 May 25:109725. doi: 10.1016/j.radonc.2023.109725.
    >> Share

  36. KAIDAR-PERSON O, Giasafaki P, Boersma L, De Brouwer P, et al
    Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925.
    Radiother Oncol. 2023;185:109698.
    >> Share

    April 2023
  37. SAIFI O, Bachir B, Panoff J, Poortmans P, et al
    Post-mastectomy Radiation Therapy in HER-2 Positive Breast Cancer after Primary Systemic Therapy: Pooled Analysis of TRYPHAENA and NeoSphere Trials.
    Radiother Oncol. 2023 Apr 6:109668. doi: 10.1016/j.radonc.2023.109668.
    >> Share

    March 2023
  38. SONG YC, Kong J, Li N, Liu XL, et al
    Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: a multicenter retrospective study.
    Radiother Oncol. 2023 Mar 27:109639. doi: 10.1016/j.radonc.2023.109639.
    >> Share

  39. VEKEN LOIC V, Ooteghem Genevieve V, Ariane R, Rita Quaresma Sergio D, et al
    Voluntary versus mechanically-induced deep inspiration breath-hold for left breast cancer: a randomized controlled trial.
    Radiother Oncol. 2023 Mar 8:109598. doi: 10.1016/j.radonc.2023.109598.
    >> Share

    January 2023
  40. LOUISE HOLM MILO M, Slot Moller D, Bisballe Nyeng T, Hoffmann L, et al
    Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation therapy techniques.
    Radiother Oncol. 2023 Jan 12:109453. doi: 10.1016/j.radonc.2022.109453.
    >> Share

    December 2022
  41. WOLFRAM S, S K Takayesu J, Pierce LJ, Jagsi R, et al
    Changes in pectoralis major stiffness and thickness following radiotherapy for breast cancer: a 12-month follow-up case series.
    Radiother Oncol. 2022 Dec 23:109450. doi: 10.1016/j.radonc.2022.109450.
    >> Share

  42. LEONARDI MC, Cormio CF, Frassoni S, Dicuonzo S, et al
    Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women.
    Radiother Oncol. 2022;177:71-80.
    >> Share

  43. KAIDAR-PERSON O, Gentilini O, Poortmans P
    Not only volumes matter for breast radiation therapy.
    Radiother Oncol. 2022;177:236-237.
    >> Share

    November 2022
  44. ALGARA M, Rodriguez E, Martinez-Arcelus FJ, Salinas J, et al
    OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial.
    Radiother Oncol. 2022;176:76-82.
    >> Share

    October 2022
  45. VISANI L, Livi L, Ratosa I, Orazem M, et al
    Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer.
    Radiother Oncol. 2022;177:40-45.
    >> Share

  46. GRAADAL SVESTAD J, Heydari M, Gyland Mikalsen S, Gordon Flote V, et al
    Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial.
    Radiother Oncol. 2022 Oct 26. pii: S0167-8140(22)04512.
    >> Share

  47. THOMSEN MS, Alsner J, Nielsen HM, Jakobsen EH, et al
    Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial.
    Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04494.
    >> Share

  48. LAZZARI G, Rago L, Solazzo AP, Benevento I, et al
    Adjuvant chemotherapy and hypofractionated whole breast cancer radiotherapy: is it time to rethink the sequencing ?
    Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04507.
    >> Share

  49. VROU OFFERSEN B, Overgaard M, Overgaard J
    Breast cancer radiotherapy: is it time to rethink the indication?
    Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04505.
    >> Share

  50. PATEL CG, Peterson J, Aznar M, Tseng YD, et al
    Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
    Radiother Oncol. 2022 Oct 14. pii: S0167-8140(22)04497.
    >> Share

  51. TUDDA A, Castriconi R, Benecchi G, Cagni E, et al
    Knowledge-based multi-institution plan prediction of whole breast irradiation with tangential fields.
    Radiother Oncol. 2022;175:10-16.
    >> Share

    September 2022
  52. GOEL V, Sharma D, Sharma A, Mallick S, et al
    A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer.
    Radiother Oncol. 2022;176:59-67.
    >> Share

  53. MULLIEZ T, De Ridder M
    Pre-OPerative Accelerated breast Radio Therapy (POPART): a largely unknown world.
    Radiother Oncol. 2022;174:170.
    >> Share

  54. CHAKRABORTY S, Chatterjee S
    HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis.
    Radiother Oncol. 2022;174:59-68.
    >> Share

    July 2022
  55. IATI G, Tuscano C, Al Sayyad S
    Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study" by Mulliez et al. (March 2022, Volume 170).
    Radiother Oncol. 2022 Jul 8. pii: S0167-8140(22)04190.
    >> Share

  56. KAIDAR-PERSON O, Fortpied C, Hol S, Weltens C, et al
    The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial.
    Radiother Oncol. 2022;172:99-110.
    >> Share

    June 2022
  57. CHEVLI N, Haque W, Tran KT, Farach AM, et al
    21- gene recurrence score predictive for prognostic benefit of radiotherapy in patients age >/=70 with T1N0 ER/PR+ HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
    Radiother Oncol. 2022 Jun 27. pii: S0167-8140(22)04174.
    >> Share

  58. MIRJOLET C, Diallo I, Bertaut A, Veres C, et al
    Treatment related factors associated with the risk of breast radio-induced-sarcoma.
    Radiother Oncol. 2022;171:14-21.
    >> Share

    May 2022
  59. ALMBERG SS, Lervag C, Frengen J, Eidem M, et al
    Training, validation, and clinical implementation of a deep-learning segmentation model for radiotherapy of loco-regional breast cancer.
    Radiother Oncol. 2022 May 23. pii: S0167-8140(22)02269.
    >> Share

    April 2022
  60. BUELENS P, Ir SW, I LV, Crijns W, et al
    Clinical Evaluation of a Deep Learning Model for Segmentation of Target Volumes in Breast Cancer Radiotherapy.
    Radiother Oncol. 2022 Apr 18. pii: S0167-8140(22)00221.
    >> Share

  61. FATTAHI S, Mullikin TC, Aziz KA, Afzal A, et al
    Proton therapy for the treatment of inflammatory breast cancer.
    Radiother Oncol. 2022 Apr 15. pii: S0167-8140(22)00189.
    >> Share

    March 2022
  62. BEDDOK A, Kirova Y, Laki F, Reyal F, et al
    The place of the boost in the breast cancer treatment: State of art.
    Radiother Oncol. 2022 Mar 17. pii: S0167-8140(22)00146.
    >> Share

  63. OVERGAARD M, Nielsen HM, Tramm T, Hojris I, et al
    Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the danish breast cancer cooperative group DBCG 82bc trial.
    Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00133.
    >> Share

  64. MULLIEZ T, Miedema G, Van Parijs H, Hottat N, et al
    Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): a feasibility study.
    Radiother Oncol. 2022 Mar 4. pii: S0167-8140(22)00117.
    >> Share

  65. JOO JH, Yang JD, Park HY, Park J, et al
    The patterns and spatial locations of local recurrence in breast cancer with implant-based reconstruction after mastectomy.
    Radiother Oncol. 2022 Mar 1. pii: S0167-8140(22)00113.
    >> Share

    February 2022
  66. CHAN J, Brown E, Dennis K, Milosevic M, et al
    Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
    Radiother Oncol. 2022;167:122-126.
    >> Share

    January 2022
  67. LEONARDI MC, Pepa M, Luraschi R, Vigorito S, et al
    The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: an AIRO multi-institutional study.
    Radiother Oncol. 2022 Jan 13. pii: S0167-8140(22)00008.
    >> Share

  68. GAIDE O, Herrera F, Sozzi WJ, Goncalves Jorge P, et al
    Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.
    Radiother Oncol. 2022 Jan 5. pii: S0167-8140(21)09093.
    >> Share

  69. LADBURY C, Liu J, Radany E, Vora N, et al
    An examination of nationwide trends in accelerated partial breast irradiation - The replacement of breast brachytherapy with intraoperative radiotherapy and external beam radiation.
    Radiother Oncol. 2022;166:79-87.
    >> Share

    December 2021
  70. BAKKER A, Valverde CPT, van Tienhoven G, Kolff MW, et al
    Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: temperature matters.
    Radiother Oncol. 2021 Dec 29. pii: S0167-8140(21)09084.
    >> Share

  71. GROOT KOERKAMP ML, van der Leij F, van 't Westeinde T, Bol GH, et al
    Prone vs. supine accelerated partial breast irradiation on an MR-Linac: A planning study.
    Radiother Oncol. 2021;165:193-199.
    >> Share

    November 2021
  72. KAO YS
    Comment to "long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost".
    Radiother Oncol. 2021 Nov 29. pii: S0167-8140(21)09012.
    >> Share

  73. PRICE AT, Kennedy WR, Henke LE, Brown SR, et al
    Implementing stereotactic accelerated partial breast irradiation using magnetic resonance guided radiation therapy.
    Radiother Oncol. 2021;164:275-281.
    >> Share

  74. BOURGIER C, Cowen D, Castan F, Lemanski C, et al
    Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.
    Radiother Oncol. 2021;164:57-65.
    >> Share

  75. DECESARIS CM, Mossahebi S, Jatczak J, Rao AD, et al
    Outcomes of and treatment planning considerations for a hybrid technique delivering proton pencil-beam scanning radiation to women with metal-containing tissue expanders undergoing post-mastectomy radiation.
    Radiother Oncol. 2021;164:289-298.
    >> Share

    October 2021
  76. ISABELLE CHOI J, Khan AJ, Powell SN, McCormick B, et al
    Proton Reirradiation for Recurrent or New Primary Breast Cancer in the Setting of Prior Breast Irradiation.
    Radiother Oncol. 2021 Oct 21. pii: S0167-8140(21)08777.
    >> Share

  77. IMANE A, Gestel Dirk V, Olga K, Carine K, et al
    Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: differences between tangential beam and VMAT.
    Radiother Oncol. 2021 Oct 11. pii: S0167-8140(21)08761.
    >> Share

  78. DUANE FK, Kerr A, Wang Z, Darby SC, et al
    Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
    Radiother Oncol. 2021 Oct 6. pii: S0167-8140(21)08753.
    >> Share

  79. VIANI GA, Gouveia AG, Louie AV, Korzeniowski M, et al
    Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis.
    Radiother Oncol. 2021 Oct 5. pii: S0167-8140(21)08752.
    >> Share

  80. ROJAS DP, Leonardi MC, Frassoni S, Morra A, et al
    Implant risk failure in patients undergoing postmastectomy 3-week hypofractionated radiotherapy after immediate reconstruction.
    Radiother Oncol. 2021;163:105-113.
    >> Share

  81. SPOOR DS, Sijtsema NM, van den Bogaard VAB, van der Schaaf A, et al
    Validation of separate multi-atlases for auto segmentation of cardiac substructures in CT-scans acquired in deep inspiration breath hold and free breathing.
    Radiother Oncol. 2021;163:46-54.
    >> Share

    September 2021
  82. KAIDAR-PERSON O, Dahn HM, Nichol AM, Boersma LJ, et al
    A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer.
    Radiother Oncol. 2021 Sep 23. pii: S0167-8140(21)06735.
    >> Share

  83. HAQUE W, Singh A, Verma V, Schwartz MR, et al
    Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
    Radiother Oncol. 2021;162:52-59.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016